CClinicalTrials.gg
CompletedNCT00475839Updated Jan 10, 2013

Study Comparing Tension-free Vaginal Tape With the Monarc Procedure for Stress Urinary Incontinence

A Phase 3 interventional study of Tension-free Vaginal Tape and Monarc sub-fascial hammock in Stress Urinary Incontinence, sponsored by The Cleveland Clinic. Completed at 3 sites in United States. Open to female participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2013-01-10.

Sponsored by The Cleveland Clinic · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
21 Years and older
Sex
Female
01

Study summary

Urinary incontinence is a major health issue in women. It is estimated to affect 30 - 40% of older women. Stress urinary incontinence, the most common form of this disease, is treated primarily with surgery. A woman's lifetime risk of surgery for SUI is 4%, with nearly 1/3 of surgery being performed for recurrences. Many different surgical procedures have been described for the treatment of SUI and there is no general agreement as to the most effective. This study compares the safety and efficacy of the tension-free vaginal tape procedure to the Monarc subfascial hammock procedure in the treatment of stress urinary incontinence.

02

Conditions studied

  • Stress Urinary Incontinence

Keywords

  • stress urinary incontinence
  • sling procedures
  • tension-free vaginal tape
  • transobturator
03

In context

Urinary Incontinence

1,363 studies on the registry are indexed under Urinary Incontinence; 228 are open to participants now.

This study's enrollment of 180 is above the median of 66 across 1,011 interventional studies indexed under Urinary Incontinence.

Browse Urinary Incontinence studies →

Lead sponsor

The Cleveland Clinic is the lead sponsor of 818 studies on the registry; 118 are open to participants now.

Of its 89 completed or terminated interventional studies of FDA-regulated products, 72 (81%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Urinary incontinence symptoms
  • Urodynamic stress incontinence confirmed with multichannel urodynamic testing
  • Age of at least 21 years
  • Desires surgical correction of stress urinary incontinence

Exclusion criteria

Exclusion Criteria:

  • Post-void residual volume >100cc
  • Detrusor overactivity on preoperative multichannel urodynamic testing
  • History of previous synthetic, biologic or fascial sub-urethral sling
  • Desires future childbearing
  • Chronic inguinal or vulvar abscess or history of Hidradenitis Suppurativa
  • History of bleeding diathesis or current anti-coagulation therapy
  • Inguinal lymphadenopathy or inguinal/vulvar mass
  • Current genitourinary fistula or urethral diverticulum
  • Reversible cause of incontinence (i.e. drug effect)
  • Contraindication to surgery
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single
Enrollment
180 participants (actual)

Study arms

  • Active comparator
    Tension-free Vaginal Tape

    Device: Tension-free Vaginal Tape

  • Active comparator
    Monarc Sub-fascial hammock

    Device: Monarc sub-fascial hammock

Interventions

  • DeviceTension-free Vaginal Tape
  • DeviceMonarc sub-fascial hammock
06

What researchers measure

Primary outcomes

  1. The presence of abnormal bladder function, defined as the sign or symptom of urinary incontinence or urinary retention

    Time frame: 12 months

Secondary outcomes

  1. Complications

  2. Postoperative pain

    Time frame: 2 weeks, 6 weeks

  3. HRQOL

    Time frame: 6 months, 12 months, 18 months, 24 months

  4. Sexual function

    Time frame: 12 months, 24 months

  5. Global improvement in bladder function

    Time frame: 6 months, 12 months, 18 months, 24 months

  6. Development of anterior vaginal prolapse

    Time frame: 12 months, 24 months

07

Study locations

3 sites
  • Greater Baltimore Medical Center
    Baltimore, Maryland 21204, United States
  • Good Samaritan Hospital
    Cincinnati, Ohio 45520, United States
  • Cleveland Clinic
    Cleveland, Ohio 44195, United States
08

References and documents

Publications

  • Barber MD, Kleeman S, Karram MM, Paraiso MF, Walters MD, Vasavada S, Ellerkmann M. Transobturator tape compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstet Gynecol. 2008 Mar;111(3):611-21. doi: 10.1097/AOG.0b013e318162f22e. PubMed 18310363 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 10, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00475839
Lead sponsor
The Cleveland Clinic
Collaborators
Good Samaritan Hospital, Ohio, Greater Baltimore Medical Center, American Medical Systems
First posted
May 21, 2007
Start date
Dec 2004
Completion
Jul 2007
Last update
Jan 10, 2013

Study contacts

Matthew D Barber, MD, MHS
principal investigator · The Cleveland Clinic

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion